Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Comptroller and health directors flag rising pharmacy costs and GLP‑1 drugs as a major fiscal pressure
Summary
The state’s comptroller and health benefits staff told lawmakers that sharp growth in GLP‑1 prescriptions, specialty biologics and weakening rebate rates are a key driver of deficit pressures across state retiree plans, active‑employee health plans and Medicaid.
State fiscal managers and the comptroller’s office told the Appropriations Committee that pharmacy costs are a cross‑cutting driver of multiple agency shortfalls, and that recent changes in drug use and pricing are creating budget uncertainty.
Comptroller’s overview: Tara Downs, the deputy comptroller, described several lines of deficiency work the office handles and introduced the agency’s witnesses. The comptroller’s health and benefits staff described 2 primary pharmacy-related pressures: rapid uptake of GLP‑1 medications (used for diabetes and recently for…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
